Repono (544463)

Score breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 37.84% and profit growth of 22.81% show strong expansion momentum.
• ROCE of 47.51% indicates highly efficient use of capital and a possible competitive moat.
• P/E of 10.82 with PEG of 0.36 suggests the stock is cheap relative to its growth rate.
• Piotroski F-score of 7/9 reflects solid financial health and operational discipline.
• Latest quarter revenue of ₹30 crore and net profit of ₹3 crore show continuing business activity.

Concerns

• Zero dividend yield means total return depends entirely on capital gains.
• Missing data on book value, debt/equity, and promoter holding limits margin-of-safety assessment.
• Profit growth of 22.81% is lower than sales growth of 37.84%, implying possible margin pressure.
• Small market cap of ₹62 crore can lead to low liquidity and high price volatility.

AI Analysis

At ₹60, Repono has a market cap of only ₹62 crore and a P/E of 10.82. That is a modest price for a business growing sales at 37.84% and profits at 22.81%. The PEG ratio of 0.36 tells me the market is paying far too little for this growth. ROCE of 47.51% is remarkable; the company is earning nearly 48 paise for every ₹1 of capital employed, which often signals a genuine moat in oil storage and transportation. The Piotroski F-score of 7 out of 9 also gives me comfort on financial health. The latest quarter shows sales of ₹30 crore and net profit of ₹3 crore, so momentum appears intact. However, I cannot ignore what is missing. Book value, debt-to-equity, promoter holding, and dividend yield are not available. As Graham would say, margin of safety requires knowing what you own. A zero dividend means small shareholders must rely entirely on capital appreciation, which is acceptable only if the business keeps compounding. I am also cautious because this is a small-cap at just ₹62 crore, so liquidity and volatility are real risks. Profit growth at 22.81% trails sales growth at 37.84%, suggesting margins may be under pressure. I would not buy blindly. This is a fast grower with exceptional returns on capital and a cheap valuation, but I need more disclosures before treating it as a core holding. I would start small, monitor quarterly results, and only add if management proves it can convert this growth into sustainable free cash flow.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer